Table 2.
Patient | Control value range a | |||
---|---|---|---|---|
% | Absolute (cells/μl) | % | Absolute (cells/μl) | |
T cells | ||||
CD3+ | 6.01 | 182 | 54.28-71.67 | 2179-4424 |
CD3+CD4+ | 1.54 | 47 | 33.72-52.43 | 1461-3018 |
CD3+CD8+ | 4.06 | 123 | 14.08-24.70 | 556-1687 |
CD4+CD45RA+ | 6.87 | 13 | 69.15-88.10 | 1170-2595 |
CD8+CD45RA+ | 16.61 | 31 | 68.90-94.60 | 503-1276 |
B cells | ||||
CD19+ | 0.82 | 25 | 17.34-36.03 | 734-2265 |
NK cells | ||||
CD3-CD56+ | 5.10 | 154 | 5.89-14.85 | 290-780 |
1–6 months (14).